SQUAWK/NEWS
Menu
Live News EARNINGS ARTICLE L impact

ClearPoint Neuro Lowers FY2026 Sales Guidance from $52.000M-$56.000M to $48.000M-$52.000M vs $53.133M Est

ClearPoint Neuro (NASDAQ: CLPT ) lowers FY2026 sales outlook from $52.000 million-$56.000 million to $48.000 million-$52.000 million vs $53.133 million estimate.

CLPT

ClearPoint Neuro (NASDAQ: CLPT ) lowers FY2026 sales outlook from $52.000 million-$56.000 million to $48.000 million-$52.000 million vs $53.133 million estimate.